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The sequence of 4968 (or 4976 with an insertion) amino acids composing the ryanodine receptor from rabbit cardiac sarcoplasmic reticulum has 
been deduced by cloning and sequencing the cDNA. This protein is homologous in amino acid sequence and shares characteristic structural features 
with the skeletal muscle ryanodine receptor. Xenopus oocytes injected with mRNA derived from the cardiac ryanodine receptor cDNA exhibit 
Ca*+-dependent Cl- current in response to caffeine, which indicates the formation of functional calcium release channels. RNA blot hybridization 
analysis with a probe specific for the cardiac ryanodine receptor mRNA shows that the stomach and brain contain a hybridizable RNA species 
with a size similar to that of the cardiac mRNA. This result, in conjunction with cloning and analysis of partial cDNA sequences, suggests that 
the brain contains a cardiac type of ryanodine receptor mRNA. 
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1. INTRODUCTION 
The ryanodine receptor in the sarcoplasmic reticulum 
(SR) functions as a calcium release channel and is most 
likely involved in the Ca2+ release that triggers muscle 
contraction [ 11. This receptor protein is thought to 
form a homo-tetrameric complex with the 
characteristic ‘foot’ structure [2] which spans the gap 
between the SR and transverse tubule (T-tubule) mem- 
branes. Cloning and sequence analysis of cDNA have 
revealed that the rabbit skeletal muscle ryanodine 
receptor is composed of 5037 amino acid residues with 
the carboxy-terminal transmembrane region which pro- 
bably forms the calcium release channel and the re- 
maining portion which apparently constitutes the foot 
structure [3]. It has also been shown that the skeletal 
muscle ryanodine receptor, expressed in Chinese 
hamster ovary cells, functions as an intracellular 
calcium release channel [4]. 
muscle dihydropyridine receptor cDNA in dysgenic 
mouse skeletal muscle has been shown to restore E-C 
coupling which resembles that of cardiac and skeletal 
muscle, respectively [5-71. However, possible involve- 
ment of the ryanodine receptor in determining the type 
of E-C coupling remains to be investigated. Previous 
studies have shown that the cardiac and the skeletal 
muscle ryanodine receptor exhibit some differences in 
properties including molecular size, sensitivity to 
ligands and antigenicity [S-14]. 
The present investigation deals with cloning and se- 
quencing of cDNA encoding the ryanodine receptor 
from rabbit heart and with expression in Xenopus 
oocytes of functional calcium release channels from the 
cloned cDNA. Evidence has been obtained to suggest 
that a cardiac type of ryanodine receptor mRNA is pre- 
sent in the brain and probably also in the stomach. 
The mechanism of excitation-contraction (E-C) 
coupling in cardiac muscle differs from that in skeletal 
muscle in that entry of extracellular Ca2+ is required 
for contraction of cardiac muscle, but not of skeletal 
muscle [l]. Expression of the cardiac and the skeletal 
2. MATERIALS AND METHODS 
2.1. Cloning and sequencing of cDNAs 
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Abbreviations: SR, sarcoplasmic reticulum; T-tubule, transverse 
tubule; E-C coupling, excitation-contraction coupling; IPs, inositol 
1,4,5trisphosphate 
Total RNA was extracted [15] from adult rabbit heart and po- 
ly(A)+ RNA was isolated [16]. An oligo(dT)-primed, size-selected 
(2 1 kilobase pairs (kb)) cDNA library [17], constructed in hgtl0 us- 
ing rabbit heart poly(A)+ RNA, was screened with the 
Sma1(13290)/Sma1(15181) fragment from clone pRR616 [3] to yield 
AHRRlO and AHRRl2; restriction endonuclease sites are identified 
by numbers (in parentheses) indicating the 5’-terminal nucleotide 
generated by cleavage. The cDNA inserts of XHRRlO and AHRRl2 
were subcloned into the EcoRI site of pBluescript KS( +) (Stratagene) 
to yield pHRRl0 and pHRRl2, respectively. A randomly primed, 
size-selected (~1 kb) cDNA library, constructed in pBluescript 
KS(+) as in [3], was screened four times with different probes: the 
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Fig. 1. Nucleotide sequence of cloned cDNA encoding the rabbit cardiac ryanodine receptor together with the preceding genomic DNA sequence 
(top) and alignment of the deduced amino acid sequence (in one-letter code) of the rabbit cardiac ryanodine receptor (C, middle) with that of 
the rabbit skeletal muscle ryanodine receptor (Sk, bottom). The sequence data for the rabbit skeletal muscle ryanodine receptor have been taken 
from [3]. The nucleotide SeotrPnces determined with the cloned cDNA and genomic DNA are shown in capital and small letters, respectively. 
Nucleotide residues are numbered in the 5’ to 3’ direction from the first residue of the ATG initiation triplet and the preceding residues are 
indicated by negative numbers. Amino acid residues are numbered from the initiating methionine. Numbers of the nucleotide and amino acid 
residues at the right-hand end of the individual lines are given. Sets of identical amino acid residues are enclosed with solid lines, and sets of 
conservative residues [26] with broken lines. Deletions and insertions in the amino acid sequence of the rabbit skeletal muscle ryanodine receptor, 
as compared with that of the rabbit cardiac ryanodine receptor, are indicated by gaps (-) and triangles (with the number of inserted residues 
in parentheses), respectively. The putative mRNA start site is marked with an asterisk. Sequences of the GC box and the polyadenylation signal 
are underlined. Nucleotide residue 16247 is followed by a poly(dA) tract. The putative transmembrane segments Ml-M4 are indicated; the termini 
of each segment are tentatively assigned by comparison with the rabbit skeletal muscle ryanodine receptor. The nucleotide differences observed 
among the individual clones are as follows: G (pHRRlO5, pHRR158 and three other clones) or A (pHRR160) at residue 5341; insertion (pHRR10 
and another clone) or deletion (pHRR60 and three other clones) of residues 11 146-11 169 (overlined). The resulting amino acid substitutions are 
as follows: E or K at residue 1781; insertion/deletion of residues 371663723. The first-named (or inserted) residues are given in the sequences 
presented. 
0.50-kb EcoRI(vector)/HincII(l2025) fragment from pHRRl2 yield- 
ed five positive clones including pHRR60; the 0.72.kb EcoRI(vec- 
tor)/HincI1(7584) fragment from pHRR60 yielded pHRRlO5; the 
0.38kb EcoRI(vector)/EcoRI(5444) fragment from pHRR105 yield- 
ed four positive clones including pHRRl58 and pHRR160; and the 
0.24.kb EcoRI(vector)/Bg01(1921) fragment from pHRR160 yielded 
pHRR25 1. A synthetic primer complementary to nucleotide residues 
1235-1251, prepared using an automatic DNA synthesizer (Applied 
Biosystems), was elongated by the procedures described previously 
[3] and the resulting clones were selected with the 0.29.kb EcoRI(vec- 
tor)/Bg/I(1220) fragment from pHRR251 to yield pHRR404, which 
carried the 5 ‘-terminal cDNA sequence. Another oligo(dT)-primed, 
size-selected (2 1 kb) cDNA library, constructed in pBluescript 
KS(+) as in 131. was screened with the 2.1-kb 
PvuII(l4114)/EcoRI(vector) fragment from pHRR12 to yield 
pHRR501. Nested deletions were made [18] and DNA sequencing 
[19] was carried out on both strands, except for portions of the 
3 ’ -noncoding sequence following nucleotide residue 14999. The 
cDNA clones used for nucleotide sequence analysis were as follows: 
pHRR404 (carrying nucleotides -313 to 1251). pHRR251 
(934-2512), pHRRl60 (1690-5508; residues 1949-2149 were not se- 
quenced), pHRR158 (2714-5614; residues 2993-4841 were not se- 
quenced), pHRRlO5 (5071-9003), pHRR60 (6869912497 with a 
deletion of 11 146-l 1 169; residues 7205-8784 and 11704-12233 not 
sequenced), pHRRl0 (10975-14998; residues 11258814675 not se- 
quenced), pHRRl2 (II 527-16207) and pHRR501 (13321-16247); 
residues 13 545-15 993 not sequenced). 
A rabbit genomic DNA clone (hHRRG3), which contained a 
5’.flanking sequence and the putative first exon (extending to 
nucleotide residue 48) of the cardiac ryanodine receptor gene, was 
isolated by screening a Charon 4A library [20] with the 
PsfI( -292)/PsrI( -153) fragment from pHRR404 as probe. The 
-15.kb EcoRV fragment and the -5-kb EarnHI fragment from 
hHRRG3 were subcloned into pBluescript SK( -) for sequence 
analysis. 
An oligo(dT)-primed, size-selected (zf 1 kb) cDNA library was con- 
strutted in hgt 10 using poly(A)+ RNA from adult rabbit brain as in 
[171. The library was screened with the 2.1-kb 
PvuII(14 114)/EcoRI(vector) fragment from pHRRl2 to yield 9 
positive clones includingABRR58 and XBRR59. The cDNA inserts of 
the 9 clones were subcloned into pBluescript KS( +) and analysed 
with restriction endonucleases (digestion with HinfI, with Dral plus 
Sac1 and with EcoRI plus HincII). Both ends of the cDNAs carried 
by the plasmids pBRR58 and pBRR59 were sequenced. 
2.2. Synthesis of specific mRNA 
Recombinant plasmids carrying the cDNA for the cardiac 
ryanodine receptor with (pSPCRR200) or without the 24nucleotide 
insertion (pSPCRR51) were constructed as follows. The 
SacIl( -49)/A&1(1 107) fragment from pHRR404 and the 4.3.kb 
A&1(1 107/SacII(vector) fragment from pHRR251 were ligated to 
yield pCRR10. pCRRl0 was digested with Sncll and ligated with the 
synthetic SacII-.%/I adaptor 5 ’ GTCGACGC-3 ’ (prepared using the 
automatic DNA synthesizer) to yield pCRRl3. The 
CluI(2352)/BumHI(4867) fragment from pHRRl60, the 
BamHI(4867)/EcoRI(5444) fragment from pHRR158 and the 
EcoRI/CluI fragment from pBluescript SK( -) were ligated to yield 
pCRR21. The 2.4-kb SuLI(adaptor)/C/uI(2352) fragment from 
pCRRl3, the C~aI(2352)/EcoR1(5444) fragment from pCRR21 and 
the EcoRI/Su/I fragment from pBluescript KS( +) were ligated to 
yield pCRR31. The Xmu1(5418)/PstI(8956) fragment from 
pHRRlO5, the Pst1(8956)/Accl(ll649) fragment from pHRR60, the 
4.6.kb Accl(ll649)/EcoRI(vector) fragment from pHRR12 and the 
EcoRI/Xmul fragment from pBluescript KS( +) were ligated to yield 
pCRR40. The 5.5.kb Su/I(adaptor)/XmuI(5418) fragment from 
pCRR31, the 12.6.kb XmuI(5418)/Scal(vector) fragment from 
pCRR40 and the 1. I-kb Scal/SuiI fragment from pBluescript SK( -) 
were ligated to yield pCRR51. The C/uI(lO483)/PvuIl(lO999) frag- 
ment from pHRR60, the PvuII(10999)/SucII(ll227) fragment from 
pHRRl0 and the SucII/C/uI fragment from pBluescript SK( -) were 
ligated to yield pCRR100. The XmuI(5418)/CluI(lO483) fragment 
from pCRR40, the C/uI(l0483)/SucII(I 1227) fragment from 
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pCRRlK’ and the 13.5.kb vector-containing 
Sacll( 11227)/X/nu1(5418) fragment from pCRR5I were ligated to 
yield pCRR200. Finally the 16.3-kb So/l fragment containing the en- 
tire protein-coding sequence from pCRR5l (or pCRR200) was cloned 
into the Sal1 site of pSP64A.x [21] to yield pSPCRR5l (or 
pSPCRR200). mRNA specific for the cardiac ryanodine receptor was 
syntherired in vitro [22], uring X/w-cleaved pSPCRR5 I (or 
pSPCRR200) as template. Transcription was primed with the cap 
dinucteotide rn-G(S’)ppp(S’)G (I mhl) [23]. 
The tnRN.4 specific for the cardiac rqanodine receptor was injected 
into Xeno~us laevis oocytes (mRNA concentration I .O pg//ll; average 
volume injected per ooc)-te, -50 nl). The injected oocytes were in- 
cubated at 19°C for 4-6 days as in 1241. All electrophysiological 
measurements were performed in nominally Ca”-free Ringer’s solu- 
tion (I I5 mM NaCI, 2.5 m%l KCt, 1.8 m.M MgCtr, IO mM Hepes, 
pH adjusted to 7.2 \vith NaOH) unless otherwite specified. Wholc- 
cell currents were recorded ai in [24]. 
3. RESULTS 
3.1. DNA cloning 
An oligo(dT)-primed cDNA library prepared from 
rabbit heart poly(A)+ RNA was screened by hybridiza- 
tion with a probe derived from the rabbit skeletal mus- 
cle ryanodine receptor cDNA. A fragment from an 
initial clone thus isolated was used to probe a randomly 
primed cDNA library for adjacent cDNA sequences 
and such procedures were repeated successively (see 
section 2.1). 
To locate the mRNA start site, we cloned and se- 
quenced rabbit genomic DNA corresponding to the 
5’ -terminal region of the cDNA. Primer extension ex- 
periments with the synthetic primers complementary to 
nucleotide residues -245 to -206 and to residues -265 
to -236 (for residue numbers, see Fig. 1) yielded major 
products of -130 and -100 nucleotides, respectively. 
On the basis of these results and of the fact that 
eukaryotic mRNAs generally start with an A residue 
[25], the start site of the cardiac ryanodine receptor 
mRNA was tentatively assigned to the A residue -334 
(Fig. 1). There are three overlapping copies of the GC 
box (residues -398 to -393, -394 to -389 and -390 
to -385) upstream of the mRNA start site, but neither 
the CAAT box nor the TATA box is found. The 
skeletal muscle ryanodine receptor gene contains two 
GC box sequences at similar positions and a CAAT box 
sequence located between them [3]. The genomic DNA 
sequence corresponding to residues -313 to 48 of the 
cDNA is uninterrupted and residue 48 (followed by 
GTAAGC) is encompassed by a potential splice donor 
site [25]. This indicates that the coding sequence for the 
amino-terminal 16 amino acid residues of the cardiac 
ryanodine receptor is followed by an intron, as is the 
case for the skeletal muscle counterpart [3]. 
3.2. Protein structure 
Fig. 1 shows the amino acid sequence of the rabbit 
cardiac ryanodine receptor, deduced from the cDNA 
sequence using the open reading frame of the rabbit 
skeletal muscle ryanodine receptor cDNA. The 
nucleotide sequence surrounding the translational in- 
itiation codon agrees reasonably well with the consen- 
sus sequence [27]. Nucleotide residues 11 146-11 169 
(encoding amino acid residues 3716-3723) are deleted 
in some clones. The insertion/deletion may be ac- 
counted for by alternative RNA splicing. The rabbit 
cardiac ryanodine receptor is composed of 4968 (or 
4976 with the insertion) amino acid residues, its 
calculated M, (including the initiating methionine) be- 
ing 565057 (or 565901 with the insertion). The 
3 ‘-noncoding region of the cDNA is 1319 nucleotides 
long (excluding the poly(dA) tract); the polyadenyla- 
tion signal ATTAAA [28] is found 14 nucleotides 
upstream from the poly(dA) tract. 
The amino acid sequence of the rabbit cardiac 
ryanodine receptor shows 66% identity with that of the 
rabbit [3] (or human [29]) skeletal muscle ryanodine 
receptor; for evaluating sequence similarity, inser- 
tions/deletions have been counted as one substitution 
regardless of their length. The hydropathicity profile of 
the cardiac ryanodine receptor (Fig. 2A) is similar to 
that of the skeletal muscle counterpart in that there are 
four highly hydrophobic segments (referred to as Ml, 
M2, M3 and M4) in the carboxy-terminal tenth of the 
molecule, that the remaining region is largely 
hydrophilic and that there is no hydrophobic amino- 
terminal sequence indicative of the signal sequence. 
Fig. 2B shows the profile of local amino acid sequence 
identity between the rabbit cardiac and skeletal muscle 
ryanodine receptors. The carboxy-terminal region that 
encompasses segments M3 and M4 is highly conserved, 
whereas other regions, for example, the region im- 
mediately preceding segment M 1 and the region around 
position 1350 are rather divergent. The cardiac 
ryanodine receptor contains four repeated sequences 
occurring in two tandem pairs (amino acid residues 
853-966, 967-1082, 2692-2810 and 28 1 l-2925), as 
described for the skeletal muscle counterpart [29]. 
3.3. RNA blot hybridization analysis and cloning of 
partial cDNA sequences from brain 
RNA preparations from different rabbit tissues were 
subjected to blot hybridization analysis with a probe 
derived from the 3 ‘-noncoding region of the cardiac 
ryanodine receptor cDNA (Fig. 3). The heart contained 
a hybridizable RNA species of - 17 kilobases (lane 1). 
The size of this RNA agrees with our assignment of the 
mRNA start site and the polyadenylation site. A small 
amount of a hybridizable RNA species with a similar 
size was found in the stomach (lane 4) and in the brain 
(lane 2). No hybridizable RNA species was detected in 
the skeletal muscle (lane 3) and kidney (lane 5). 
To identify the hybridizable RNA present in the 
brain, we screened a cDNA library derived from rabbit 
brain poly(A)’ RNA using a cardiac ryanodine recep- 
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Fig. 2. (A) Hydropathicity profile of the rabbit cardiac ryanodine receptor. The averaged hydropathicity index [30] of a nonadecapeptide 
composed of amino acid residues i-9 to i+9 is plotted against i, where i represents the amino acid number. (B) Profile of local amino acid 
sequence identity between the rabbit cardiac and skeletal muscle ryanodine receptors. The percent sequence identity of a segment corresponding 
to positions j-9 to j+9 is plotted against j, where j represents the position number; deletions and insertions (see Fig. 1) have been counted as 
one position regardless of their length. The horizontal line in B indicates the overall percent sequence identity between the two ryanodine receptors 
(66%). The positions of the putative transmembrane segments Ml-M4 are shown by filled boxes. 
tor cDNA probe and obtained 9 positive clones. 
Restriction endonuclease analysis showed that all these 
clones yielded fragments common to those derived 
from the 3’-terminal region of the cardiac ryanodine 
12345 
Origin - 
23- 
4.4- 
Fig. 3. Autoradiogram of blot hybridization analysis of RNA from 
adult rabbit tissues with a cDNA probe specific for the cardiac 
ryanodine receptor mRNA. Total RNA from heart (10 ,~g, lane 1) 
and poly(A)’ RNA from brain (5 fig, lane 2), skeletal muscle (10 Fg, 
lane 3), stomach (30 pg. lane 4) and kidney (3O,~g, lane 5) were 
analysed as in [31]; the hybridization probe used was the 0.75.kb 
HincII(l5 463)/EcoRI(vector) fragment from pHRR12, labelled by 
the random primer method [32]. Autoradiography was performed at 
-70°C for 7 days with an intensifying screen. The size markers used 
were the Hind111 cleavage products of phage XDNA (sizes in 
kilobases). 
receptor cDNA (see section 2.1). Sequence analysis of 
two of these clones showed that they carried at least the 
sequences of nucleotide residues 14 389- 14687 and 
15944-16247 (pBRR58) and of residues 14759-14981 
and 15971-16247 (pBRR59) of the cardiac ryanodine 
receptor cDNA. These results indicate that the cardiac 
ryanodine receptor gene is transcribed in the brain. 
However, the brain mRNA may not be identical with 
the cardiac ryanodine receptor mRNA because 
transcription may be initiated at different promoters 
and/or because the transcription product may be sub- 
ject to alternative splicing. The same may hold for the 
puiative stomach ryanodine receptor mRNA. 
3.4. Functional expression of cDNA 
Recombinant plasmids carrying the entire protein- 
coding sequence of the cardiac ryanodine receptor 
cDNA (pSPCRR51 encoding 4968 amino acids and 
pSPCRR200 encoding 4976 amino acids with the inser- 
tion) were constructed and transcribed in vitro. Each of 
the resulting mRNAs was injected into Xenopus 
oocytes. The oocytes were tested for calcium release 
channel activity by measuring Ca*+-dependent Cl- cur- 
rent [33,34] that would occur in response to caffeine. 
Fig. 4A(a) exemplifies a caffeine-induced response 
of an injected oocyte in nominally Cazf-free Ringer’s 
solution. An inward current occurred after a substan- 
tial delay (9 t 3 s (mean + SD), n = 16, n indicating 
the number of oocytes; the dead-space time in the per- 
fusion system has been subtracted). At -70 mV mem- 
brane potential, the peak inward current elicited by 
50 mM caffeine (applied for 20 s) was 1.5 + 1.3 ,uA 
(n = 14, excluding 5 unresponsive oocytes). The caf- 
feine response was almost completely abolished by in- 
tracellular injection of the calcium-chelating agent 
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Fig. 4. (A) Caffeine response recorded from a Xenopus oocyte 
injected with the mRNA derived from the cloned rabbit cardiac 
ryanodine receptor cDNA. Whole-cell currents evoked by bath 
application of 50 mM caffeine were recorded under voltage clamp at 
-70 mV membrane potential in nominally Ca’+-free Ringer’s 
solution before (a) and after (b) intracellular injection of EGTA. 
Inward current is downward, The duration of caffeine application is 
indicated by bars without taking into account the dead-space time in 
the perfusion system (-7 s). EGTA was injected ionophoretically 
into the oocyte as in [35], except that the duration of injection was 
10 min. (B) Peak current-voltage (1-V) relations (inward current 
shown as negative current) obtained from an injected oocyte in 
nominally Ca “-free Ringer’s solution (0) and in the solution in 
which half of the Cl- was replaced by methanesulphonate (0). 
Currents evoked by bath application of 50 mM caffeine for IO s were 
recorded under voltage clamp at different membrane potentials. The 
data shown were from oocytes injected with the mRNA derived from 
clone pSPCRR51. Essentially the same results were obtained with 
oocytes injected with the mRNA derived from clone pSPCRR200. 
EGTA (Fig. 4A(b)). No detectable response (< 10 nA) 
was observed in 31 non-injected oocytes; some non- 
injected oocytes showed a marginal outward current 
(21 f 7 nA, n = 10) or a marginal inward current 
(21 f 7 nA, n = 5) or both (an outward current of 
20 nA followed by an inward current of 30 nA, n = 1). 
Fig. 4B shows the membrane potential dependence 
of the caffeine response. The reversal potential of the 
caffeine-induced current, measured in nominally 
Ca’+-free Ringer’s solution (filled circles), was -23 k 
3 mV (n = 6). This is close to the equilibrium potential 
of chloride ions observed in Xenopus oocytes [33]. The 
reversal potential shifted to -6 ? 3 mV (n = 6) when 
the external Cl- concentration was halved by substitu- 
tion with methanesulphonate (open circles), but it did 
not significantly change when the external Na+ was 
replaced by K+ (-26 k 3 mV, n = 5) or when the exter- 
nal K+ was replaced by Na’ (-24 & 3 mV, n = 5). 
These results indicate that the caffeine-induced cur- 
rent is carried by chloride ions and that this Cll current 
results from Ca2+ being released from an intracellular 
store in response to caffeine. Thus we conclude that 
functional calcium release channels are formed in 
Xenopus oocytes by expression of the cardiac 
ryanodine receptor cDNA. 
4. DISCUSSION 
The structural similarity demonstrated in the present 
investigation suggests that the cardiac ryanodine recep- 
tor, like its skeletal muscle counterpart [3], consists of 
two main parts, that is, the carboxy-terminal channel 
region which contains four putative transmembrane 
segments (Ml-M4) and the large cytoplasmic region 
which corresponds to the foot structure; the presence of 
several additional potential transmembrane segments in 
the skeletal muscle ryanodine receptor has been propos- 
ed [29]. The carboxy-terminal region, including 
segments M3 and M4, is highly conserved between the 
cardiac and skeletal muscle ryanodine receptors. This 
region also shows remarkable amino acid sequence 
similarity to the carboxy-terminal region of the inositol 
1,4,5-trisphosphate (IP3) receptor [36]. Both the 
ryanodine receptor and the IPj receptor mediate release 
of Ca2+ from intracellular stores, as demonstrated by 
reconstitution of the purified protein into phospholipid 
bilayer membranes or vesicles [lo- 13,371 and by func- 
tional expression of the cloned cDNA (see section 3.4 
and [4,38]). Thus the carboxy-terminal region of both 
the receptors may be important in forming intracellular 
membrane channels. 
The SR calcium release channel is activated or in- 
hibited by various modulators, including Ca2+, adenine 
nucleotides, caffeine, calmodulin and polycationic 
compounds [l]. The regions encompassing amino acid 
residues 1336-1347 and 2010-2021 of the cardiac 
ryanodine receptor bear some resemblance to the EF- 
hand [39], but are not well conserved in the skeletal 
muscle ryanodine receptor. The cardiac ryanodine 
receptor has four copies of the nucleotide-binding con- 
sensus sequence GXGXXG [40] (residues 1324- 1329, 
2337-2342, 2626-2631 and 4352-4357), one of which 
(residues 2337-2342) is conserved in the skeletal muscle 
counterpart. Two potential calmodulin-binding sites 
[41] (residues 3581-3604 and 4257-4285) are found in 
the cardiac ryanodine receptor and one of them 
(residues 3581-3604) is particularly well conserved in 
the skeletal muscle counterpart. The observation that 
the region preceding and close to segment Ml is 
relatively divergent in amino acid sequence between the 
cardiac and skeletal muscle ryanodine receptors does 
not seem to favour our previous suggestion that this 
region contains putative modulator-binding sites [3]. It 
has been reported that the cardiac ryanodine receptor 
is phosphorylated by cyclic AMP-dependent protein 
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kinase [42]. The cardiac ryanodine receptor contains 
seven potential cyclic AMP-dependent phosphoryiation 
sites 1431 (serine residues ZOS(i,2808,4701 and 4702 and 
threanine residues 2044, 2057 and 4283), ah of which 
are Xocated on the putative cytoplasmic side according 
to our transmembsane model; residue 4283 is conserved 
in both the rabbit and human skeletal muscle ryanodine 
receptors. 
Several investigators have observed caffeine-induced 
Ca2+ release in neurons 144-461. ~~e~tro~-rn~~ros~opi& 
studies have revealed that junctions between the surface 
membrane and the subsurface cisternae of endoplasmic 
reticulum in neurons have structural features similar to 
those of the junctions between the T-tubule membrane 
and the terminal cisternae of SR in striated muscte 
147,451. 6?h-&l~ ZiRd ~~~~~~~~~~~~~ Of IX&& cDMA se- 
quences and RNA blot hybridization analysis have pro- 
vided evidence that the brain contains a cardiac type of 
ryanodine receptor mKNA (see section 3.3). These fin- 
dings together suggest that the cardiac type (and 
possibly other types) of ryanod~ne receptor may be pre- 
sent in the ju~~ti~~al membrane of the subsurface 
cisternae of neurons, taking part in Ca2+ signalling. 
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